The Oncology Institute, Inc. (TOI) has a MoatMap StockRank of 77/100 based on Quality (34/100), Value (55/100), and Momentum (72/100) factor scores. The current signal is BUY.
The Oncology Institute, Inc. is a leading provider of advanced oncology care, offering a comprehensive suite of services including chemotherapy, radiation, clinical trials, and supportive care. It operates a network of cancer treatment centers, primarily serving communities in California, Nevada, and Arizona, focusing on value-based care models. The Oncology Institute is a vertically integrated provider in the niche market of specialized cancer treatment, aiming to improve patient outcomes and accessibility.
| Price | $4.71 |
| Market Cap | $471M |
| P/E (Forward) | -28.69 |
| Price/Book | -28.87 |
| Return on Invested Capital | -52.8% |
| Gross Margin | 15.1% |
| Operating Margin | -4.4% |
| Revenue Growth | 41.2% |
| Free Cash Flow | $-15M |
The Oncology Institute, Inc. operates in the Medical Care Facilities industry, part of the Healthcare sector (United States).